切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2023, Vol. 12 ›› Issue (03) : 155 -158. doi: 10.3877/cma.j.issn.2095-3259.2023.03.008

胎盘植入性疾病

胎盘植入性疾病的不良结局及远期影响
张丽姿, 陈敦金()   
  1. 510150 广州医科大学附属第三医院妇产科 广东省产科重大疾病重点实验室 广州重症孕产妇救治中心 粤港澳母胎医学高校联合实验室 广东省母胎医学工程技术研究中心 广东省妇产疾病临床医学研究中心
  • 收稿日期:2023-07-17 出版日期:2023-08-18
  • 通信作者: 陈敦金
  • 基金资助:
    国家重点研发计划(2022YFC2704500、2022YFC2704501); 国家自然科学基金(81830045、82171666、82071652)

Adverse outcomes and long­term prognosis of placenta accreta spectrum disorders

Lizi Zhang, Dunjin Chen()   

  • Received:2023-07-17 Published:2023-08-18
  • Corresponding author: Dunjin Chen
引用本文:

张丽姿, 陈敦金. 胎盘植入性疾病的不良结局及远期影响[J]. 中华产科急救电子杂志, 2023, 12(03): 155-158.

Lizi Zhang, Dunjin Chen. Adverse outcomes and long­term prognosis of placenta accreta spectrum disorders[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 155-158.

胎盘植入性疾病的不良结局包括子宫破裂、产后出血、输血、子宫切除、多器官损伤和孕产妇死亡等。远期影响包括宫腔粘连、闭经、再次发生胎盘植入、心理障碍和不孕等。对于高危人群应加强产前评估,早期诊断并制定个体化治疗方案,积极进行多学科团队管理和干预,以有效降低不良结局的发生率,改善患者的远期预后。

Adverse outcomes of placenta accreta spectrum disorders include uterine rupture, postpartum hemorrhage, blood transfusion, hysterectomy, multiple organ damage, maternal death, etc. Long-term effects include intrauterine adhesions, amenorrhea, recurrent placenta accreta spectrum disorders, psychological disorders and infertility. For high-risk groups, prenatal assessment, early diagnosis and individualized treatment plan should be strengthened, and MDT team management and intervention should be actively carried out to effectively reduce the incidence of adverse outcomes and improve the long-term prognosis of patients.

[1]
Irving FC, Hertig AT. A study of placenta accreta[J]. Surg Gynecol Obstet193764:178-200.
[2]
Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta praevia and placenta accreta: diagnosis and management: Green-top Guideline No. 27a[J]. BJOG2019126(1):e1-e48.
[3]
Hobson SR, Kingdom JC, Murji A, et al. No.383-Screening, diagnosis, and management of placenta accreta spectrum disorders[J]. J Obstet Gynaecol Can201941(7):1035-1049.
[4]
Jauniaux E, Ayres-de-Campos D. FIGO consensus guidelines on placenta accreta spectrum disorders: introduction[J]. Int J Gynaecol Obstet2018140(3):261-264.
[5]
The Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine. Placenta accreta spectrum[J]. Am J Obstet Gynecol, 2018, 219(6):B2-B16.
[6]
Fox H. Placenta accreta, 1945-1969[J]. Obstetrical & Gynecological Survey197227(7):475-490.
[7]
Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta[J]. Am J Obstet Gynecol196695(5):660-668.
[8]
Calì G, Timor-Tritsch IE, Palacios-Jaraquemada J, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol201851(2):169-175.
[9]
王媛媛,陈练,赵扬玉. 利用影像学指标判断胎盘植入患者不良妊娠结局[J]. 中国实用妇科与产科杂志202036(5):416-419.
[10]
Jauniaux E, Chantraine F, Silver RM, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology[J]. Int J Gynaecol Obstet2018140(3):265-273.
[11]
Mehrabadi A, Hutcheon JA, Liu S, et al. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage[J]. Obstet Gynecol2015125(4):814-821.
[12]
Allen L, Jauniaux E, Hobson S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management[J]. Int J Gynaecol Obstet2018140(3):281-290.
[13]
Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders[J]. Best Pract Res Clin Obstet Gynaecol202172:84-91.
[14]
Schwickert A, van Beekhuizen HJ, Bertholdt C, et al. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): a multinational database study[J]. Acta Obstet Gynecol Scand2021100 Suppl 1:29-40.
[15]
Shamshirsaz AA, Fox KA, Erfani H, et al. Coagulopathy in surgical management of placenta accreta spectrum[J]. Eur J Obstet Gynecol Reprod Biol2019237:126-130.
[16]
Sentilhes L, Kayem G, Chandraharan E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management[J]. Int J Gynaecol Obstet2018140(3):291-298.
[17]
American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Obstetric care consensus No.7: placenta accreta spectrum[J]. Obstet Gynecol2018132(6):e259-e275.
[18]
Gatta LA, Weber JM, Gilner JB, et al. Transfusion requirements with hybrid management of placenta accreta spectrum incorporating targeted embolization and a selective use of delayed hysterectomy[J]. Am J Perinatol202229(14):1503-1513.
[19]
Ramdhan RC, Loukas M, Tubbs RS. Anatomical complications of hysterectomy: a review[J]. Clin Anat201730(7):946-952.
[20]
O′Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies[J]. Am J Obstet Gynecol1996175(6):1632-1638.
[21]
Jauniaux E, Bunce C, Grønbeck L, et al. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis[J]. Am J Obstet Gynecol2019221(3):208-218.
[22]
Wang YL, Weng SS, Huang WC. First-trimester abortion complicated with placenta accreta: a systematic review[J]. Taiwan J Obstet Gynecol201958(1):10-14.
[23]
Li J, Zhang Y, Tian F, et al. Subtotal hysterectomy causes fewer long-term detrimental effects on ovary tissues than total hysterectomy[J]. Histol Histopathol2023:1-17.
[24]
Aleixo GF, Fonseca MCM, Bortolini MAT, et al. Total versus subtotal hysterectomy: systematic review and meta-analysis of intraoperative outcomes and postoperative short-term events[J]. Clin Ther201941(4):768-789.
[25]
Neis F, Reisenauer C, Kraemer B, et al. Retrospective analysis of secondary resection of the cervical stump after subtotal hysterectomy: why and when?[J]. Arch Gynecol Obstet2021304(6):1519-1526.
[26]
Michelet D, Ricbourg A, Gosme C, et al. Emergency hysterectomy for life-threatening postpartum haemorrhage: risk factors and psychological impact[J]. Gynecol Obstet Fertil201543(12):773-779.
[27]
Steins Bisschop CN, Schaap TP, Vogelvang TE, et al. Invasive placentation and uterus preserving treatment modalities: a systematic review[J]. Arch Gynecol Obstet2011284(2):491-502.
[28]
Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta[J]. Hum Reprod201025(11):2803-2810.
[29]
Abd Elazeem HAS, Saad MM, Ahmed IA, et al. High-intensity focused ultrasound in management of placenta accreta spectrum: a systematic review[J]. Int J Gynaecol Obstet2020151(3):325-332.
[30]
Eshkoli T, Weintraub AY, Sergienko R, et al. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births[J]. Am J Obstet Gynecol2013208(3):219.e1-219.e7.
[31]
Cauldwell M, Chandraharan E, Pinas Carillo A, et al. Successful pregnancy outcome in woman with history of Triple-P procedure for placenta percreta[J]. Ultrasound Obstet Gynecol201851(5):696-697.
[32]
张丽姿,杜丽丽,赵会丹,等. 胎盘植入性疾病孕妇Triple-P手术后的再次妊娠结局分析[J]. 中华妇产科杂志2023(1):44-48.
[1] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[2] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[3] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[4] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[5] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[6] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[7] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[8] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[9] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[10] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[11] 钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[12] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要